Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Recent MOVE News & Updates

Narrative Update • Sep 15

MOVE: Execution On 2026 Guidance And Investment Discipline Will Support Future Upside

Analysts have trimmed their overall fair value estimate for Medacta Group from about CHF 179 to about CHF 168. This reflects updated assumptions for slightly softer revenue growth, a modestly lower future P/E and ongoing investment needs highlighted in recent research that includes a new Hold initiation and a reduced CHF 180 price target.

New Narrative • Sep 15

Global Procedure Growth And Geographic Expansion Will Shape A Stronger Orthopaedics Leader

Catalysts About Medacta Group Medacta Group develops and supplies orthopaedic implants and related surgical technologies across Hip, Knee, Spine, Extremities and Sports Medicine. What are the underlying business or industry changes driving this perspective?

Analysis Article • Sep 13

Analyst Estimates: Here's What Brokers Think Of Medacta Group SA (VTX:MOVE) After Its Half-Yearly Report

Medacta Group SA ( VTX:MOVE ) shareholders are probably feeling a little disappointed, since its shares fell 9.8% to...

Recent updates

No updates

Medacta Group SA Competitors

MOVE Share Price Performance

MOVE Community Narratives

Earnings Guidance And Updated Outlook Will Drive Expansion Across New Markets

Global Procedure Growth And Geographic Expansion Will Shape A Stronger Orthopaedics Leader

Earnings Guidance And Updated Outlook Will Drive Expansion Across New Markets

Global Procedure Growth And Geographic Expansion Will Shape A Stronger Orthopaedics Leader

Trending Discussion

Recently Updated Narratives

MOVE: Execution On 2026 Guidance And Investment Discipline Will Support Future Upside

Global Procedure Growth And Geographic Expansion Will Shape A Stronger Orthopaedics Leader

Snowflake Analysis

Medacta Group SA Key Details

About MOVE

Recent MOVE News & Updates

MOVE: Execution On 2026 Guidance And Investment Discipline Will Support Future Upside

Global Procedure Growth And Geographic Expansion Will Shape A Stronger Orthopaedics Leader

Analyst Estimates: Here's What Brokers Think Of Medacta Group SA (VTX:MOVE) After Its Half-Yearly Report

Recent updates

Medacta Group SA Competitors

Ypsomed Holding

Galenica

Aevis Victoria